DCL: Explanation for business result in the first half of 2011
Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO) has explained the fluctuation in profit after tax of the parent company between the financial statements and the consolidated financial statements in the first six months of 2011:
- Profit after tax in the financial statements: VND 26,621,927,672
- Profit after tax in the consolidated financial statements: VND 17,268,726,252
Reasons:
- Interest expense for Caps Plant, undistributed antibiotic: VND 2,648,940,380
- Selling expense: VND 19,848,161,162
- Unrecorded returns: VND 16,919,097,783
- Provision for inventory and receivables: VND 3,354,544,850
- Other expenses: VND 1.119.909.749
Total: VND 43,890,653,924
hose
|